 NOVATO, CA ACCESSWIRE October 1, 2021 Mosaic ImmunoEngineering Inc. Mosaic or the Company, OTCQB:CPMV, a development-stage biotechnology company focused on bridging immunology and engineering to develop novel immunotherapies to treat and prevent cancer and infectious diseases, today announced that Nicole F. Steinmetz, Ph.D. 